Concepedia

David Back

DB

Statistics

Publications

243

Citations

12.8K

H-Index

58

Active since

1972

Affiliations

University of Liverpool(Current)

Chelsea and Westminster Hospital

Liverpool School of Tropical Medicine

Trinity College Dublin

University of Turin

David Back is an author at University of Liverpool specializing in pharmacology, pharmacokinetics, and antiretroviral therapy.

ORCID

Publications per year

1972–2021

243

Publications

243

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

Jacques Fellay, Catia Marzolini, E. Rhiannon Meaden et al. · The Lancet · 2002 · 662 citations · Full text

, , +17

Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes

Victoria A. Eagling, John Tjia, David Back · British Journal of Clinical Pharmacology · 1998 · 336 citations · Full text

, , +14

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

Victoria A. Eagling, David Back, Michael Barry · British Journal of Clinical Pharmacology · 1997 · 336 citations · Full text

, , +17

St John's Wort increases expression of P‐glycoprotein: Implications for drug interactions

Martina Hennessy, Dermot Kelleher, Paul Spiers et al. · British Journal of Clinical Pharmacology · 2002 · 278 citations · Full text

, , +17

Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

Sonia Rodríguez‐Nóvoa, Pablo Labarga, Vincent Soriano et al. · Clinical Infectious Diseases · 2009 · 241 citations · Full text

, , +17

1–5 of 243